Healthcare - Biotechnology - NASDAQ - US
$ 50.22
-8.19 %
$ 5.93 B
Market Cap
-9.33
P/E
BALANCE SHEET
824 M
ASSETS
1.21 B
LIABILITIES
-386 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cytokinetics, Incorporated
| Current Assets | 628 M |
| Cash & Short-Term Investments | 615 M |
| Receivables | 1.28 M |
| Other Current Assets | 11.9 M |
| Non-Current Assets | 196 M |
| Long-Term Investments | 40.5 M |
| PP&E | 148 M |
| Other Non-Current Assets | 8 M |
| Current Liabilities | 103 M |
| Accounts Payable | 21.5 M |
| Short-Term Debt | 45.9 M |
| Other Current Liabilities | 35.3 M |
| Non-Current Liabilities | 1.11 B |
| Long-Term Debt | 728 M |
| Other Non-Current Liabilities | 380 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||||||
| Cash & Cash Equivalents | 113.0 | 65.6 | 112.7 | 83.0 | 36.4 | 42.3 | 125.2 | 66.9 | 65.1 | 20.2 | 20.2 | 14.9 | 18.8 | 17.5 | 25.6 | 41.8 | 116.6 | 39.4 | 13.5 | 13.1 | 11.0 | 16.4 | 0 | 0 |
| Short Term Investments | 501.8 | 717.0 | 359.0 | 381.1 | 188.7 | 156.5 | 143.7 | 89.4 | 46.4 | 63.0 | 57.6 | 59.1 | 30.2 | 54.1 | 89.2 | 15.0 | 3.2 | 70.2 | 62.7 | 92.6 | 24.2 | 10.4 | 0 | 0 |
| Receivables | 1.3 | 0.1 | 51.8 | 4.4 | 5.2 | 6.8 | 1.1 | 24 K | 12 K | 46.6 | 5 K | 4 K | 14 K | 46 K | 0.2 | 0.3 | 0.2 | 42.2 | 0.7 | 0.8 | 0.3 | 16 K | 0 | 0 |
| Inventory | 0 | (0.1) | (51.8) | (4.4) | 0 | (6.8) | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.9 | 12.5 | 12.2 | 5.7 | 7.0 | 2.2 | 8.6 | 2.4 | 1.5 | 1.1 | 1.4 | 4.8 | 2.1 | 1.8 | 2.0 | 1.8 | 2.1 | 1.8 | 1.9 | 2.6 | 1.6 | 1.1 | 0 | 0 |
| Total Current Assets | 628.1 | 795.2 | 535.7 | 474.2 | 233.8 | 207.7 | 274.3 | 158.6 | 113.1 | 131.1 | 79.3 | 76.4 | 51.1 | 73.5 | 116.9 | 58.9 | 122.0 | 153.6 | 78.9 | 109.1 | 37.1 | 27.9 | 0 | 0 |
| PP&E | 147.7 | 163.2 | 146.4 | 22.6 | 13.4 | 3.2 | 3.6 | 3.6 | 1.8 | 1.6 | 1.2 | 1.0 | 1.3 | 2.3 | 3.7 | 5.1 | 7.7 | 9.2 | 6.2 | 7.3 | 8.9 | 9.7 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 40.5 | 46.7 | 152.1 | 37.0 | 42.6 | 0 | 16.5 | 7.7 | 0.2 | 0 | 2.5 | 0 | 0 | 1.2 | 1.7 | 20.0 | 20.0 | 0 | 0 | 4.6 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 8.0 | 9.7 | 7.2 | 0 | 0 | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 1.0 | 0.3 | 3.5 | 5.6 | 6.7 | 6.4 | 7.1 | 16.9 | 18.5 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 79.0 | 61.0 |
| Total Assets | 824.3 | 1 014.8 | 841.3 | 533.8 | 289.8 | 211.2 | 294.8 | 170.1 | 115.2 | 133.0 | 83.2 | 77.6 | 52.8 | 78.0 | 122.6 | 87.5 | 155.4 | 169.5 | 91.5 | 128.1 | 62.9 | 56.2 | 79.0 | 61.0 |
| LIABILITIES | ||||||||||||||||||||||||
| Accounts Payable | 21.5 | 25.6 | 21.1 | 8.1 | 8.2 | 3.8 | 5.3 | 4.2 | 2.2 | 1.4 | 3.7 | 2.2 | 1.2 | 1.1 | 1.7 | 1.4 | 1.6 | 2.8 | 2.4 | 2.1 | 1.6 | 1.6 | 0 | 0 |
| Short Term Debt | 45.9 | 25.7 | 29.7 | 5.6 | 9.2 | 2.6 | 0 | 2.5 | 0 | 0 | 0 | 0 | 0.2 | 0.8 | 1.6 | 2.0 | 4.0 | 3.7 | 2.7 | 2.4 | 2.0 | 2.4 | 0 | 0 |
| Other Current Liabilities | 35.3 | 33.3 | 21.0 | 17.6 | 8.6 | 15.8 | 17.6 | 18.5 | 8.6 | 5.5 | 8.3 | 5.0 | 3.2 | 5.4 | 16.1 | 7.2 | 8.6 | 7.6 | 4.8 | 3.8 | 3.1 | 2.2 | 0 | 0 |
| Total Current Liabilities | 102.7 | 84.6 | 71.9 | 31.2 | 26.0 | 22.2 | 32.4 | 33.3 | 31.6 | 23.9 | 26.7 | 5.8 | 4.6 | 7.3 | 20.2 | 22.9 | 26.4 | 26.4 | 11.3 | 11.0 | 9.5 | 9.4 | 0 | 0 |
| Long Term Debt | 727.8 | 736.5 | 255.1 | 136.2 | 131.5 | 40.6 | 31.8 | 27.4 | 14.6 | 0 | 0 | 0 | 0 | 0 | 2.0 | 5.2 | 9.3 | 14.3 | 6.6 | 16.2 | 8.1 | 7.1 | 3.5 | 1.1 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.4) | 0 | 0 | 0 | 0 | 0 | 0 | (12.2) | (24.4) | (29.7) | 0 | (1.4) | 0 | 0 | 0 | 0 |
| Other Liabilities | 380.2 | 301.5 | 183.5 | 166.1 | 143.3 | 122.5 | 105.7 | 0.1 | 0.4 | 0.5 | 0.5 | 0.4 | 3 K | 0 | (1.0) | (2.6) | (4.6) | (7.1) | 0 | (8.1) | 137.4 | 100.3 | (3.5) | (1.1) |
| Total Liabilities | 1 210.6 | 1 122.7 | 597.5 | 420.4 | 300.8 | 185.2 | 185.0 | 75.8 | 46.6 | 40.9 | 28.7 | 6.1 | 4.6 | 7.5 | 21.2 | 37.7 | 55.5 | 63.2 | 17.9 | 20.5 | 154.9 | 116.8 | 116.4 | 82.9 |
| EQUITY | ||||||||||||||||||||||||
| Common Stock | 0.1 | 94 K | 84 K | 70 K | 59 K | 768.8 | 54 K | 41 K | 40 K | 39 K | 31 K | 0.1 | 75 K | 67 K | 61 K | 50 K | 49 K | 43 K | 30 K | 28 K | 2 K | 2 K | 0 | 0 |
| Retained Earnings | (2 112.2) | (1 586.0) | (1 207.6) | (992.3) | (865.0) | (743.3) | (646.1) | (518.3) | (534.7) | (497.2) | (482.6) | (448.9) | (408.5) | (360.6) | (311.4) | (335.9) | (279.5) | (230.6) | (173.5) | (131.3) | (94.1) | (61.4) | (38.3) | (22.4) |
| Other Accumulative Comprehensive Income/Loss | 10 K | (3.6) | (0.9) | 0.1 | 0.7 | 0.5 | 0.3 | 0.1 | 0.1 | 4 K | 7 K | 18 K | 3 K | 4 K | 1 K | 18 K | (0.3) | (1.2) | (2.5) | (4.4) | (3.6) | 10 K | 0 | 0 |
| Total Equity | (386.3) | (107.9) | 243.9 | 113.4 | (10.9) | 25.9 | 109.8 | 94.4 | 68.6 | 92.1 | 54.4 | 71.4 | 48.2 | 70.5 | 101.4 | 49.8 | 99.9 | 106.3 | 73.6 | 107.6 | (92.0) | (60.6) | (37.4) | (21.8) |
| Total Liabilities and Equity | 824.3 | 1 014.8 | 841.3 | 533.8 | 289.8 | 211.2 | 294.8 | 170.1 | 115.2 | 133.0 | 83.2 | 77.6 | 52.8 | 78.0 | 122.6 | 87.5 | 155.4 | 169.5 | 91.5 | 128.1 | 62.9 | 56.2 | 79.0 | 61.0 |
| SHARES OUTSTANDING | ||||||||||||||||||||||||
| Common Shares Outstanding | 96.5 | 89.8 | 76.9 | 64.5 | 57.6 | 54.4 | 49.4 | 39.9 | 38.7 | 35.7 | 27.3 | 18.1 | 11.8 | 10.7 | 9.6 | 8.2 | 7.9 | 6.1 | 4.8 | 3.3 | 0.3 | 0.3 | 0.2 | 0.2 |